Genomic therapy developer EdiGene, electric vehicle rental platform Go Sharing and API management platform developer RapidAPI have all raised about $60m.
Funding
China-headquartered genomic drug developer EdiGene has closed a RMB400m ($61.6m) series B-plus round featuring Lilly Asia Ventures, a corporate venturing vehicle for pharmaceutical firm Eli Lilly. The round was led by Loyal Valley Capital and included BioTrack Capital, Sherpa Healthcare Partners and existing backers including IDG Capital, 3H Health Investment, Huagai Capital, Sequoia Capital China, Alwin Capital and Kunlun Capital. The company had raised over $100m in total as of its last round, a $66.8m series B backed by…
